GEODE CAPITAL MANAGEMENT, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$972,371
-26.6%
94,405
+17.4%
0.00%
Q2 2023$1,325,024
+80.8%
80,402
+0.5%
0.00%
Q1 2023$732,827
+129374.7%
80,003
+1.2%
0.00%
Q4 2022$566
-99.7%
79,079
+95.1%
0.00%
Q3 2022$203,000
+107.1%
40,5280.0%0.00%
Q2 2022$98,000
-64.5%
40,5280.0%0.00%
Q1 2022$276,000
-15.6%
40,5280.0%0.00%
Q4 2021$327,000
-17.6%
40,5280.0%0.00%
Q3 2021$397,000
+46.0%
40,5280.0%0.00%
Q2 2021$272,000
-29.0%
40,528
-4.5%
0.00%
Q1 2021$383,000
+66.5%
42,445
+22.8%
0.00%
Q4 2020$230,000
+32.2%
34,5520.0%0.00%
Q3 2020$174,000
-21.3%
34,552
+26.1%
0.00%
Q2 2020$221,000
+6.8%
27,395
+4.9%
0.00%
Q1 2020$207,000
-70.3%
26,113
-71.8%
0.00%
Q4 2019$696,000
+262.5%
92,440
+100.0%
0.00%
Q3 2019$192,000
+44.4%
46,2200.0%0.00%
Q2 2019$133,000
+150.9%
46,220
+24.9%
0.00%
Q1 2019$53,000
-72.1%
36,999
-50.0%
0.00%
Q4 2018$190,000
+17.3%
73,998
+100.0%
0.00%
Q3 2018$162,000
-28.3%
36,9990.0%0.00%
Q2 2018$226,000
+145.7%
36,999
+191.8%
0.00%
Q1 2018$92,000
-10.7%
12,6800.0%0.00%
Q4 2017$103,000
-55.4%
12,680
-42.5%
0.00%
Q3 2017$231,000
-37.1%
22,052
-33.8%
0.00%
Q2 2017$367,000
+21.5%
33,326
+6.6%
0.00%
Q1 2017$302,00031,2630.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders